Takeda's Weber: ‘Everything Relies On Our Ability To Deliver Innovative Medicines’

With the formal completion of its huge acquisition of Shire now just a day away, some eight months after it was first announced, Takeda CEO presses home what he sees as the key priorities and benefits of the combined operation - but the real work to realize these is just beginning.